Aider les femmes à traverser la ménopause: rôle des pharmaciens

Hersh AL Stefanick ML Stafford RS . National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004;291:47–53.

Kase NG . Impact of hormone therapy for women aged 35 to 65 years, from contraception to hormone replacement. Gend Med 2009;6(1):37–9.

Reid RL Blake J Abramson B SOGC menopause and osteoporosis update 2009. J Obstet Gynaecol Can 2009;31(1):S1–S46.

North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 2010;17(2):242–55.

Conboy L Domar A O'Connel E . Women at mid-life: symptoms, attitudes, and choices, an internet based survey. Maturitas 2001;38:129–36.

McIntosh J Blalock SJ . Effects of media coverage of Women's Health Initiative study on attitudes and behaviour of women receiving hormone replacement therapy. Am J Health Syst Pharm 2005;62:69–74.

Lewis V . Undertreatment of menopausal symptoms and novel options for comprehensive management. Current Med Res Option 2009;25(11):2689–98.

Barner JC Branvold A . Patients' willingness to pay for pharmacist-provided menopause and hormone replacement therapy consultations. Res Social Admin Pharm 2005;1:77–100.

Schonberg MA Wee CC . Menopausal symptom management and prevention counselling after the Women's Health Initiative among women seen in an internal medicine practice. J Women's Health 2005;14:507–14.

Zoella MM Ceruli J . Assessment of the effects of a community pharmacy women's health education program on management of menopause survey scores. J Manag Care Pharm 2004;10(5):42–8.

Fistonic I Franic D Popic J Adherence with hormone replacement therapy in menopause. Climacteric 2010 Feb 5; [Epub ahead of print].